Colleen Kelley

Colleen Kelley is an Assistant Professor in the Department of Epidemiology at Emory University. Her work focuses on HIV/AIDS prevention, infectious disease epidemiology, and clinical trials evaluating biomedical interventions. She has contributed to studies on long-acting antiretroviral therapies, vaccine efficacy assessment, and public health policy for equitable healthcare access. Dr. Kelley’s research integrates immunological, pharmacological, and behavioral approaches to address HIV transmission dynamics and improve prevention strategies for vulnerable populations.

Education: MD and MPH from Emory University.

Key research interests include HIV prevention equity, microbial networks analysis, and the impact of hormone therapy on HIV susceptibility. Her studies often involve marginalized groups such as transgender individuals and men who have sex with men. She has led clinical trials evaluating monoclonal antibodies, post-exposure prophylaxis, and mpox-HIV coinfection immunity.

Recent publications highlight advancements in drug delivery systems, vaccine development, and mitigating antimicrobial resistance through prophylaxis strategies. Her work bridges laboratory science with real-world public health applications, emphasizing methodological innovations like the TestNet microbial network analysis tool.

Notable contributions include policy recommendations for equitable access to long-acting HIV treatments and analysis of SARS-CoV-2 viral load dynamics in unvaccinated populations. Dr. Kelley collaborates across disciplines to address emerging infectious diseases and optimize healthcare outcomes for at-risk communities.